Prognosis after aortic valve replacement with a bioprosthesis: Predictions based on meta-analysis and microsimulation

Bioprostheses are widely used as an aortic valve substitute, but knowledge about prognosis is still incomplete. The purpose of this study was to provide insight into the age-related life expectancy and actual risks of reoperation and valve-related events of patients after aortic valve replacement wi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Circulation (New York, N.Y.) N.Y.), 2001-03, Vol.103 (11), p.1535-1541
Hauptverfasser: PUVIMANASINGHE, J. P. A, STEYERBERG, E. W, TAKKENBERG, J. J. M, EIJKEMANS, M. J. C, VAN HERWERDEN, L. A, BOGERS, A. J. J. C, HABBEMA, J. D. F
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1541
container_issue 11
container_start_page 1535
container_title Circulation (New York, N.Y.)
container_volume 103
creator PUVIMANASINGHE, J. P. A
STEYERBERG, E. W
TAKKENBERG, J. J. M
EIJKEMANS, M. J. C
VAN HERWERDEN, L. A
BOGERS, A. J. J. C
HABBEMA, J. D. F
description Bioprostheses are widely used as an aortic valve substitute, but knowledge about prognosis is still incomplete. The purpose of this study was to provide insight into the age-related life expectancy and actual risks of reoperation and valve-related events of patients after aortic valve replacement with a porcine bioprosthesis. We conducted a meta-analysis of 9 selected reports on stented porcine bioprostheses, including 5837 patients with a total follow-up of 31 874 patient-years. The annual rates of valve thrombosis, thromboembolism, hemorrhage, and nonstructural dysfunction were 0.03%, 0.87%, 0.38%, and 0.38%, respectively. The annual rate of endocarditis was estimated at 0.68% for >6 months of implantation and was 5 times as high during the first 6 months. Structural valve deterioration was described with a Weibull model that incorporated lower risks for older patients. These estimates were used to parameterize, calibrate, and validate a mathematical microsimulation model. The model was used to predict life expectancy and actual risks of reoperation and valve-related events after implantation for patients of different ages. For a 65-year-old male, these figures were 11.3 years, 28%, and 47%, respectively. The combination of meta-analysis with microsimulation enabled a detailed insight into the prognosis after aortic valve replacement with a bioprosthesis for patients of different ages. This information will be useful for patient counseling and clinical decision making. It also could serve as a baseline for the evaluation of newer valve types.
doi_str_mv 10.1161/01.CIR.103.11.1535
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76989424</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>76989424</sourcerecordid><originalsourceid>FETCH-LOGICAL-c370t-869e8b9111fee7ad954d0ab84e3736f4a4106a236cfed4828875e5c9058c8c703</originalsourceid><addsrcrecordid>eNpFkFuLFDEQhYMo7rj6B3yQgOBbj6lcOolvMnhZWHARfW6q09VupC9jkl7Zf2_GHfSpOPB9h-Iw9hLEHqCFtwL2h6uvexCq5j0YZR6xHRipG22Uf8x2QgjfWCXlBXuW888aW2XNU3YBII0VDnZsu0nrj2XNMXMcCyWOayox8Duc7ognOk4YaKal8N-x3HLkfVyPac3llqrzjt8kGmIocV0y7zHTwNeFz1SwwQWn-7-9y8DnGKoU523CE_ucPRlxyvTifC_Z948fvh0-N9dfPl0d3l83QVlRGtd6cr0HgJHI4uCNHgT2TpOyqh01ahAtStWGkQbtpHPWkAleGBdcsEJdsjcPvfXlXxvl0s0xB5omXGjdcmdb77yWuoLyATy9mRON3THFGdN9B6I7jd0J6OrYNaqau9PYVXp1bt_6mYb_ynndCrw-A5gDTmPCJcT8j_NK-lr0B1ShiSc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76989424</pqid></control><display><type>article</type><title>Prognosis after aortic valve replacement with a bioprosthesis: Predictions based on meta-analysis and microsimulation</title><source>Journals@Ovid Ovid Autoload</source><source>MEDLINE</source><source>American Heart Association Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>PUVIMANASINGHE, J. P. A ; STEYERBERG, E. W ; TAKKENBERG, J. J. M ; EIJKEMANS, M. J. C ; VAN HERWERDEN, L. A ; BOGERS, A. J. J. C ; HABBEMA, J. D. F</creator><creatorcontrib>PUVIMANASINGHE, J. P. A ; STEYERBERG, E. W ; TAKKENBERG, J. J. M ; EIJKEMANS, M. J. C ; VAN HERWERDEN, L. A ; BOGERS, A. J. J. C ; HABBEMA, J. D. F</creatorcontrib><description>Bioprostheses are widely used as an aortic valve substitute, but knowledge about prognosis is still incomplete. The purpose of this study was to provide insight into the age-related life expectancy and actual risks of reoperation and valve-related events of patients after aortic valve replacement with a porcine bioprosthesis. We conducted a meta-analysis of 9 selected reports on stented porcine bioprostheses, including 5837 patients with a total follow-up of 31 874 patient-years. The annual rates of valve thrombosis, thromboembolism, hemorrhage, and nonstructural dysfunction were 0.03%, 0.87%, 0.38%, and 0.38%, respectively. The annual rate of endocarditis was estimated at 0.68% for &gt;6 months of implantation and was 5 times as high during the first 6 months. Structural valve deterioration was described with a Weibull model that incorporated lower risks for older patients. These estimates were used to parameterize, calibrate, and validate a mathematical microsimulation model. The model was used to predict life expectancy and actual risks of reoperation and valve-related events after implantation for patients of different ages. For a 65-year-old male, these figures were 11.3 years, 28%, and 47%, respectively. The combination of meta-analysis with microsimulation enabled a detailed insight into the prognosis after aortic valve replacement with a bioprosthesis for patients of different ages. This information will be useful for patient counseling and clinical decision making. It also could serve as a baseline for the evaluation of newer valve types.</description><identifier>ISSN: 0009-7322</identifier><identifier>EISSN: 1524-4539</identifier><identifier>DOI: 10.1161/01.CIR.103.11.1535</identifier><identifier>PMID: 11257081</identifier><identifier>CODEN: CIRCAZ</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams &amp; Wilkins</publisher><subject>Adolescent ; Adult ; Age Factors ; Aged ; Aged, 80 and over ; Animals ; Aortic Valve - surgery ; Biological and medical sciences ; Bioprosthesis ; Calibration ; Computer Simulation ; Decision Support Systems, Clinical ; Female ; Heart Valve Diseases - mortality ; Heart Valve Diseases - surgery ; Heart Valve Prosthesis ; Humans ; Life Expectancy ; Male ; Medical sciences ; Middle Aged ; Models, Biological ; Prognosis ; Reoperation ; Reproducibility of Results ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the heart ; Swine</subject><ispartof>Circulation (New York, N.Y.), 2001-03, Vol.103 (11), p.1535-1541</ispartof><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c370t-869e8b9111fee7ad954d0ab84e3736f4a4106a236cfed4828875e5c9058c8c703</citedby><cites>FETCH-LOGICAL-c370t-869e8b9111fee7ad954d0ab84e3736f4a4106a236cfed4828875e5c9058c8c703</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3674,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=932915$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11257081$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>PUVIMANASINGHE, J. P. A</creatorcontrib><creatorcontrib>STEYERBERG, E. W</creatorcontrib><creatorcontrib>TAKKENBERG, J. J. M</creatorcontrib><creatorcontrib>EIJKEMANS, M. J. C</creatorcontrib><creatorcontrib>VAN HERWERDEN, L. A</creatorcontrib><creatorcontrib>BOGERS, A. J. J. C</creatorcontrib><creatorcontrib>HABBEMA, J. D. F</creatorcontrib><title>Prognosis after aortic valve replacement with a bioprosthesis: Predictions based on meta-analysis and microsimulation</title><title>Circulation (New York, N.Y.)</title><addtitle>Circulation</addtitle><description>Bioprostheses are widely used as an aortic valve substitute, but knowledge about prognosis is still incomplete. The purpose of this study was to provide insight into the age-related life expectancy and actual risks of reoperation and valve-related events of patients after aortic valve replacement with a porcine bioprosthesis. We conducted a meta-analysis of 9 selected reports on stented porcine bioprostheses, including 5837 patients with a total follow-up of 31 874 patient-years. The annual rates of valve thrombosis, thromboembolism, hemorrhage, and nonstructural dysfunction were 0.03%, 0.87%, 0.38%, and 0.38%, respectively. The annual rate of endocarditis was estimated at 0.68% for &gt;6 months of implantation and was 5 times as high during the first 6 months. Structural valve deterioration was described with a Weibull model that incorporated lower risks for older patients. These estimates were used to parameterize, calibrate, and validate a mathematical microsimulation model. The model was used to predict life expectancy and actual risks of reoperation and valve-related events after implantation for patients of different ages. For a 65-year-old male, these figures were 11.3 years, 28%, and 47%, respectively. The combination of meta-analysis with microsimulation enabled a detailed insight into the prognosis after aortic valve replacement with a bioprosthesis for patients of different ages. This information will be useful for patient counseling and clinical decision making. It also could serve as a baseline for the evaluation of newer valve types.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age Factors</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Animals</subject><subject>Aortic Valve - surgery</subject><subject>Biological and medical sciences</subject><subject>Bioprosthesis</subject><subject>Calibration</subject><subject>Computer Simulation</subject><subject>Decision Support Systems, Clinical</subject><subject>Female</subject><subject>Heart Valve Diseases - mortality</subject><subject>Heart Valve Diseases - surgery</subject><subject>Heart Valve Prosthesis</subject><subject>Humans</subject><subject>Life Expectancy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Models, Biological</subject><subject>Prognosis</subject><subject>Reoperation</subject><subject>Reproducibility of Results</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the heart</subject><subject>Swine</subject><issn>0009-7322</issn><issn>1524-4539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkFuLFDEQhYMo7rj6B3yQgOBbj6lcOolvMnhZWHARfW6q09VupC9jkl7Zf2_GHfSpOPB9h-Iw9hLEHqCFtwL2h6uvexCq5j0YZR6xHRipG22Uf8x2QgjfWCXlBXuW888aW2XNU3YBII0VDnZsu0nrj2XNMXMcCyWOayox8Duc7ognOk4YaKal8N-x3HLkfVyPac3llqrzjt8kGmIocV0y7zHTwNeFz1SwwQWn-7-9y8DnGKoU523CE_ucPRlxyvTifC_Z948fvh0-N9dfPl0d3l83QVlRGtd6cr0HgJHI4uCNHgT2TpOyqh01ahAtStWGkQbtpHPWkAleGBdcsEJdsjcPvfXlXxvl0s0xB5omXGjdcmdb77yWuoLyATy9mRON3THFGdN9B6I7jd0J6OrYNaqau9PYVXp1bt_6mYb_ynndCrw-A5gDTmPCJcT8j_NK-lr0B1ShiSc</recordid><startdate>20010320</startdate><enddate>20010320</enddate><creator>PUVIMANASINGHE, J. P. A</creator><creator>STEYERBERG, E. W</creator><creator>TAKKENBERG, J. J. M</creator><creator>EIJKEMANS, M. J. C</creator><creator>VAN HERWERDEN, L. A</creator><creator>BOGERS, A. J. J. C</creator><creator>HABBEMA, J. D. F</creator><general>Lippincott Williams &amp; Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010320</creationdate><title>Prognosis after aortic valve replacement with a bioprosthesis: Predictions based on meta-analysis and microsimulation</title><author>PUVIMANASINGHE, J. P. A ; STEYERBERG, E. W ; TAKKENBERG, J. J. M ; EIJKEMANS, M. J. C ; VAN HERWERDEN, L. A ; BOGERS, A. J. J. C ; HABBEMA, J. D. F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c370t-869e8b9111fee7ad954d0ab84e3736f4a4106a236cfed4828875e5c9058c8c703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age Factors</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Animals</topic><topic>Aortic Valve - surgery</topic><topic>Biological and medical sciences</topic><topic>Bioprosthesis</topic><topic>Calibration</topic><topic>Computer Simulation</topic><topic>Decision Support Systems, Clinical</topic><topic>Female</topic><topic>Heart Valve Diseases - mortality</topic><topic>Heart Valve Diseases - surgery</topic><topic>Heart Valve Prosthesis</topic><topic>Humans</topic><topic>Life Expectancy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Models, Biological</topic><topic>Prognosis</topic><topic>Reoperation</topic><topic>Reproducibility of Results</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the heart</topic><topic>Swine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>PUVIMANASINGHE, J. P. A</creatorcontrib><creatorcontrib>STEYERBERG, E. W</creatorcontrib><creatorcontrib>TAKKENBERG, J. J. M</creatorcontrib><creatorcontrib>EIJKEMANS, M. J. C</creatorcontrib><creatorcontrib>VAN HERWERDEN, L. A</creatorcontrib><creatorcontrib>BOGERS, A. J. J. C</creatorcontrib><creatorcontrib>HABBEMA, J. D. F</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>PUVIMANASINGHE, J. P. A</au><au>STEYERBERG, E. W</au><au>TAKKENBERG, J. J. M</au><au>EIJKEMANS, M. J. C</au><au>VAN HERWERDEN, L. A</au><au>BOGERS, A. J. J. C</au><au>HABBEMA, J. D. F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognosis after aortic valve replacement with a bioprosthesis: Predictions based on meta-analysis and microsimulation</atitle><jtitle>Circulation (New York, N.Y.)</jtitle><addtitle>Circulation</addtitle><date>2001-03-20</date><risdate>2001</risdate><volume>103</volume><issue>11</issue><spage>1535</spage><epage>1541</epage><pages>1535-1541</pages><issn>0009-7322</issn><eissn>1524-4539</eissn><coden>CIRCAZ</coden><abstract>Bioprostheses are widely used as an aortic valve substitute, but knowledge about prognosis is still incomplete. The purpose of this study was to provide insight into the age-related life expectancy and actual risks of reoperation and valve-related events of patients after aortic valve replacement with a porcine bioprosthesis. We conducted a meta-analysis of 9 selected reports on stented porcine bioprostheses, including 5837 patients with a total follow-up of 31 874 patient-years. The annual rates of valve thrombosis, thromboembolism, hemorrhage, and nonstructural dysfunction were 0.03%, 0.87%, 0.38%, and 0.38%, respectively. The annual rate of endocarditis was estimated at 0.68% for &gt;6 months of implantation and was 5 times as high during the first 6 months. Structural valve deterioration was described with a Weibull model that incorporated lower risks for older patients. These estimates were used to parameterize, calibrate, and validate a mathematical microsimulation model. The model was used to predict life expectancy and actual risks of reoperation and valve-related events after implantation for patients of different ages. For a 65-year-old male, these figures were 11.3 years, 28%, and 47%, respectively. The combination of meta-analysis with microsimulation enabled a detailed insight into the prognosis after aortic valve replacement with a bioprosthesis for patients of different ages. This information will be useful for patient counseling and clinical decision making. It also could serve as a baseline for the evaluation of newer valve types.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>11257081</pmid><doi>10.1161/01.CIR.103.11.1535</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0009-7322
ispartof Circulation (New York, N.Y.), 2001-03, Vol.103 (11), p.1535-1541
issn 0009-7322
1524-4539
language eng
recordid cdi_proquest_miscellaneous_76989424
source Journals@Ovid Ovid Autoload; MEDLINE; American Heart Association Journals; EZB-FREE-00999 freely available EZB journals
subjects Adolescent
Adult
Age Factors
Aged
Aged, 80 and over
Animals
Aortic Valve - surgery
Biological and medical sciences
Bioprosthesis
Calibration
Computer Simulation
Decision Support Systems, Clinical
Female
Heart Valve Diseases - mortality
Heart Valve Diseases - surgery
Heart Valve Prosthesis
Humans
Life Expectancy
Male
Medical sciences
Middle Aged
Models, Biological
Prognosis
Reoperation
Reproducibility of Results
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the heart
Swine
title Prognosis after aortic valve replacement with a bioprosthesis: Predictions based on meta-analysis and microsimulation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T11%3A28%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognosis%20after%20aortic%20valve%20replacement%20with%20a%20bioprosthesis:%20Predictions%20based%20on%20meta-analysis%20and%20microsimulation&rft.jtitle=Circulation%20(New%20York,%20N.Y.)&rft.au=PUVIMANASINGHE,%20J.%20P.%20A&rft.date=2001-03-20&rft.volume=103&rft.issue=11&rft.spage=1535&rft.epage=1541&rft.pages=1535-1541&rft.issn=0009-7322&rft.eissn=1524-4539&rft.coden=CIRCAZ&rft_id=info:doi/10.1161/01.CIR.103.11.1535&rft_dat=%3Cproquest_cross%3E76989424%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76989424&rft_id=info:pmid/11257081&rfr_iscdi=true